Published in J Clin Endocrinol Metab on June 17, 2008
Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab (2011) 1.74
Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania. Diabetes (2009) 1.28
Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care (2010) 1.12
The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2. J Obes (2010) 1.11
Metabolic syndrome and urologic diseases. Rev Urol (2010) 1.09
Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr Rev (2012) 1.01
Cohort profile: the Boston Area Community Health (BACH) survey. Int J Epidemiol (2012) 0.99
Neuronal androgen receptor regulates insulin sensitivity via suppression of hypothalamic NF-κB-mediated PTP1B expression. Diabetes (2012) 0.92
Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies. PLoS One (2014) 0.90
Testosterone level in men with type 2 diabetes mellitus and related metabolic effects: A review of current evidence. J Diabetes Investig (2014) 0.88
A network-based approach to visualize prevalence and progression of metabolic syndrome components. PLoS One (2012) 0.84
An overview of the contribution of fatness and fitness factors, and the role of exercise, in the formation of health status for individuals who are overweight. J Diabetes Metab Disord (2012) 0.84
Testosterone and metabolic syndrome: The link. Indian J Endocrinol Metab (2012) 0.84
Metabolic syndrome, sarcopenia and role of sex and age: cross-sectional analysis of Kashiwa cohort study. PLoS One (2014) 0.82
Autocrine androgen action is essential for Leydig cell maturation and function, and protects against late-onset Leydig cell apoptosis in both mice and men. FASEB J (2014) 0.81
Diet-induced obesity and low testosterone increase neuroinflammation and impair neural function. J Neuroinflammation (2014) 0.81
Testosterone supplementation therapy in the treatment of patients with metabolic syndrome. Postgrad Med (2014) 0.81
Androgen receptor roles in insulin resistance and obesity in males: the linkage of androgen-deprivation therapy to metabolic syndrome. Diabetes (2014) 0.81
Sertoli cells maintain Leydig cell number and peritubular myoid cell activity in the adult mouse testis. PLoS One (2014) 0.80
Androgens and stroke: good, bad or indifferent? Exp Neurol (2014) 0.78
Relation of urinary stone disease with androgenetic alopecia and serum testosterone levels. Urolithiasis (2016) 0.75
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med (1998) 46.95
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
The metabolic syndrome--a new worldwide definition. Lancet (2005) 23.51
A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab (1999) 10.64
Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab (2001) 7.53
Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem (1982) 5.98
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation (2003) 5.70
Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabet Med (1999) 5.59
The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care (2003) 5.27
Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab (2002) 4.46
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia (1991) 3.48
Measuring the urologic iceberg: design and implementation of the Boston Area Community Health (BACH) Survey. Eur Urol (2007) 3.32
Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care (2004) 3.07
Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab (2004) 3.02
Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab (2005) 2.89
Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab (1999) 2.79
Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab (2002) 2.76
Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab (2000) 2.68
American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract (2003) 2.42
Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab (2000) 2.36
Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care (2002) 2.28
Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care (2000) 2.18
Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab (2006) 2.08
Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metab (2007) 1.70
Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab (1995) 1.58
Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. Am J Epidemiol (1997) 1.52
Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation (1988) 1.47
Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. Diabetes Care (2004) 1.47
Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study. J Urol (2006) 1.44
Serum androgen levels in black, Hispanic, and white men. J Clin Endocrinol Metab (2006) 1.40
Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol (1996) 1.35
Lower endogenous androgens predict central adiposity in men. Ann Epidemiol (1992) 1.32
Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome. Diabetes Obes Metab (2004) 1.29
Sex hormones and sexual function in obese men losing weight. Obes Res (2003) 1.25
Effect of testosterone on abdominal adipose tissue in men. Int J Obes (1991) 1.18
The effects of androgens on the regulation of lipolysis in adipose precursor cells. Endocrinology (1990) 1.09
Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men. Metabolism (1994) 1.05
Endogenous sex hormones and cardiovascular disease in men. J Clin Endocrinol Metab (2003) 1.04
Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study. Diabetologia (1992) 1.02
A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate. J Androl (2007) 0.92
Testosterone increases lipolysis and the number of beta-adrenoceptors in male rat adipocytes. Endocrinology (1991) 0.91
Relationships between endogenous steroid hormone, sex hormone-binding globulin and lipoprotein levels in men: contribution of visceral obesity, insulin levels and other metabolic variables. Atherosclerosis (1997) 0.91
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 7.15
Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2006) 5.58
Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care (2006) 5.44
The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther (2005) 5.42
Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab (2002) 4.46
Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med (2006) 4.09
The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc (2012) 3.45
Measuring the urologic iceberg: design and implementation of the Boston Area Community Health (BACH) Survey. Eur Urol (2007) 3.32
Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest (2007) 3.20
Prevalence of and risk factors for urine leakage in a racially and ethnically diverse population of adults: the Boston Area Community Health (BACH) Survey. Am J Epidemiol (2008) 3.02
Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab (2004) 2.73
Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) (2005) 2.63
Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab (2007) 2.58
Sleep loss and fatigue in residency training: a reappraisal. JAMA (2002) 2.55
Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med (2007) 2.54
Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care (2005) 2.52
A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab (2006) 2.41
Nocturia and quality of life: results from the Boston area community health survey. Eur Urol (2011) 2.34
Sex steroids and all-cause and cause-specific mortality in men. Arch Intern Med (2007) 2.27
The effects of sleep loss and fatigue on resident-physicians: a multi-institutional, mixed-method study. Acad Med (2004) 2.13
Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab (2006) 2.08
Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men. J Clin Endocrinol Metab (2007) 1.96
Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women. J Urol (2007) 1.94
Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum. J Clin Endocrinol Metab (2008) 1.92
Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/ EDIC study cohort. Diabetes Care (2009) 1.87
Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci U S A (2006) 1.87
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol (2005) 1.83
Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses. Eur Urol (2007) 1.79
It's about time: physicians' perceptions of time constraints in primary care medical practice in three national healthcare systems. Med Care (2010) 1.78
Age, hormones, and cognitive functioning among middle-aged and elderly men: cross-sectional evidence from the Massachusetts Male Aging Study. J Gerontol A Biol Sci Med Sci (2005) 1.76
Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management. J Reprod Med (2006) 1.66
Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab (2005) 1.64
Changes in sexual function in middle-aged and older men: longitudinal data from the Massachusetts Male Aging Study. J Am Geriatr Soc (2004) 1.64
Assessment of vulvodynia symptoms in a sample of US women: a prevalence survey with a nested case control study. Am J Obstet Gynecol (2007) 1.63
The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab (2006) 1.60
The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol (2007) 1.58
Relative contributions of modifiable risk factors to erectile dysfunction: results from the Boston Area Community Health (BACH) Survey. Prev Med (2009) 1.57
Foot musculoskeletal disorders, pain, and foot-related functional limitation in older persons. J Am Geriatr Soc (2005) 1.57
The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther (2002) 1.57
Reversible kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene. J Clin Endocrinol Metab (2004) 1.57
Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab (2007) 1.56
Relationship between lower urinary tract symptoms and erectile dysfunction: results from the Boston Area Community Health Survey. J Urol (2007) 1.55
Disparities in the prevalence of diabetes: is it race/ethnicity or socioeconomic status? Results from the Boston Area Community Health (BACH) survey. Ethn Dis (2009) 1.53
The natural progression and regression of erectile dysfunction: follow-up results from the MMAS and MALES studies. J Sex Med (2011) 1.52
The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studies. BJU Int (2007) 1.50
Factors associated with participation in breast cancer treatment clinical trials. J Clin Oncol (2006) 1.50
Association of overactive bladder and C-reactive protein levels. Results from the Boston Area Community Health (BACH) Survey. BJU Int (2011) 1.50
Treatment of symptomatic androgen deficiency: results from the Boston Area Community Health Survey. Arch Intern Med (2008) 1.49
Association of urological symptoms and chronic illness in men and women: contributions of symptom severity and duration--results from the BACH Survey. J Urol (2008) 1.49
Vulvodynia: characteristics and associations with comorbidities and quality of life. Obstet Gynecol (2006) 1.47
Sleep, fatigue, and medical training: setting an agenda for optimal learning and patient care. Sleep (2003) 1.45
Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study. J Urol (2006) 1.44
Correlates of PDE5i use among subjects with erectile dysfunction in two population-based surveys. J Sex Med (2011) 1.44
Prevalence and psychosocial correlates of symptoms suggestive of painful bladder syndrome: results from the Boston area community health survey. J Urol (2008) 1.43
Summary of the recommendations on sexual dysfunctions in men. J Sex Med (2010) 1.42
Serum androgen levels in black, Hispanic, and white men. J Clin Endocrinol Metab (2006) 1.40
Summary of the recommendations on sexual dysfunctions in women. J Sex Med (2004) 1.40
Associations between supplemental or dietary intake of vitamin C and severity of lower urinary tract symptoms. BJU Int (2015) 1.39
Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology (2003) 1.39
Characteristics of persons with overactive bladder of presumed neurologic origin: results from the Boston Area Community Health (BACH) survey. Neurourol Urodyn (2012) 1.38
Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) (2006) 1.38
The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. J Clin Endocrinol Metab (2008) 1.37
Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril (2002) 1.35
Prevalence and correlates of sexual activity and function in women: results from the Boston Area Community Health (BACH) Survey. Arch Sex Behav (2008) 1.34
The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab (2002) 1.33
The future magnitude of urological symptoms in the USA: projections using the Boston Area Community Health survey. BJU Int (2007) 1.30
Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men. Clin Endocrinol (Oxf) (2007) 1.30
Is abuse causally related to urologic symptoms? Results from the Boston Area Community Health (BACH) Survey. Eur Urol (2007) 1.29
Care seeking and treatment for urinary incontinence in a diverse population. J Urol (2007) 1.28
The validity of a single-question self-report of erectile dysfunction. Results from the Massachusetts Male Aging Study. J Gen Intern Med (2005) 1.28
Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab (2002) 1.26
Premature ejaculation: an observational study of men and their partners. J Sex Med (2005) 1.26
Association between testosterone and estradiol and age-related decline in physical function in a diverse sample of men. J Am Geriatr Soc (2008) 1.24
Testosterone, sex hormone-binding globulin, and frailty in older men. J Am Geriatr Soc (2007) 1.24
Association between smoking, passive smoking, and erectile dysfunction: results from the Boston Area Community Health (BACH) Survey. Eur Urol (2007) 1.24
The relationship of common medical conditions and medication use with symptoms of painful bladder syndrome: results from the Boston area community health survey. J Urol (2008) 1.23
Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab (2009) 1.22
The health of normally aging men: The Massachusetts Male Aging Study (1987-2004). Exp Gerontol (2004) 1.21
The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts Male Aging Study. Eur J Endocrinol (2006) 1.20
Are foot disorders associated with functional limitation and disability among community-dwelling older adults? J Aging Health (2005) 1.20
Lower urinary tract symptoms and male sexual dysfunction in Asia: a survey of ageing men from five Asian countries. BJU Int (2005) 1.20
Cortisol levels and measures of body composition in middle-aged and older men. Clin Endocrinol (Oxf) (2007) 1.20
How are patient characteristics relevant for physicians' clinical decision making in diabetes? An analysis of qualitative results from a cross-national factorial experiment. Soc Sci Med (2008) 1.19